Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
Researchers are responsible for following all applicable laboratory safety regulations and institutional protocols when handling research compounds
Presented for research literature review only Smolanka IY et al
Premature ovarian insufficiency (POI), previously referred to as premature ovarian failure or premature menopause, affecting approximately 1% of women under 40, is not only a reproductive crisis but a sentinel event with profound long-term health consequences, ranging from cardiovascular and skeletal complications to cognitive decline (Roeters van Lennep et al., 2016
Refer to the approved prescribing information for each specific product for titration guidance
Description AOD9604 (Advanced Obesity Drug 9604) is a synthetic research peptide, a fragment of human growth hormone (HGH), designed to promote fat breakdown in cells (lipolysis) and inhibit fat formation (lipogenesis) without the negative effects of full HGH, like impacting blood sugar or causing muscle / tissue growth, making it studied for weight loss and metabolic health
US$ 20.64
US$ 22.18
US$ 22.91
.svg?mw=810&hash=BF44E6E0F79CC8AF56261DA23D63DE29)
